<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2016//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_160101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">27525707</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>8</Month>
            <Day>15</Day>
        </DateCreated>
        <DateRevised>
            <Year>2016</Year>
            <Month>8</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1537-4505</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology</Title>
                <ISOAbbreviation>Otol. Neurotol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Auditory Brainstem Implantation in Neurofibromatosis Type 2: Experience From the Manchester Programme.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the experience of auditory brainstem implantation (ABI) in patients with Neurofibromatosis type 2 (NF2).</AbstractText>
                <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective case review.</AbstractText>
                <AbstractText Label="SETTING" NlmCategory="METHODS">Tertiary referral centre.</AbstractText>
                <AbstractText Label="PATIENTS" NlmCategory="METHODS">Implanted with a Cochlear ABI22 or ABI24M between 1994 and 2009 because of NF2 disease.</AbstractText>
                <AbstractText Label="INTERVENTION(S)" NlmCategory="METHODS">Rehabilitative.</AbstractText>
                <AbstractText Label="MAIN OUTCOME MEASURE(S)" NlmCategory="METHODS">Surgical complication rate; audiological outcomes.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 50 primary ABI insertions in 49 patients, including 16 inserted at the time of first side tumor removal as a sleeper, and two revision repositionings which failed to improve outcome. Postoperatively three patients had cerebrospinal fluid leaks which did not require reoperation, one patient had meningitis, and eleven patients suffered either temporary or permanent lower cranial nerve dysfunction. Twenty-nine patients became full time users; a further 12 patients became non-users. Three patients died while their device was inactive. Five patients retain serviceable contralateral hearing. Audiological open set testing of users showed means of: environmental sounds discrimination 51%; phoneme discrimination: with ABI alone 22%/lip reading (LR) 45%/ABI with LR 65%; sentence testing: with ABI alone 13%/LR 19%/ABI with LR 54%.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The majority of patients with NF2 implanted with an ABI find the device a useful aid to communication in conjunction with LR and in recognizing common environmental sounds. A small proportion gain open set discrimination. Almost a third of patients may end up as non-users. There is probably an increased risk of postoperative lower cranial nerve dysfunction so careful preoperative assessment is advised.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ramsden</LastName>
                    <ForeName>Richard Thomas</ForeName>
                    <Initials>RT</Initials>
                    <AffiliationInfo>
                        <Affiliation>*Department of Otolarygology ?Department of Audiology ?Manchester Centre for Genomic Medicine, Institute of Human Development, University of Manchester; and Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester ¡±Department of Neurosurgery, Salford Royal Hospital NHS Foundation Trust, Salford ||Institute of Cancer ?Institute of Cardiovascular Sciences, University of Manchester, Manchester Academic Health Science Centre #Business School, Manchester Metropolitan University, U.K.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Freeman</LastName>
                    <ForeName>Simon Richard Mackenzie</ForeName>
                    <Initials>SR</Initials>
                </Author>
                <Author>
                    <LastName>Lloyd</LastName>
                    <ForeName>Simon Kingsley Wickham</ForeName>
                    <Initials>SK</Initials>
                </Author>
                <Author>
                    <LastName>King</LastName>
                    <ForeName>Andrew Thomas</ForeName>
                    <Initials>AT</Initials>
                </Author>
                <Author>
                    <LastName>Shi</LastName>
                    <ForeName>Xin</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Ward</LastName>
                    <ForeName>Charlotte Lucy</ForeName>
                    <Initials>CL</Initials>
                </Author>
                <Author>
                    <LastName>Huson</LastName>
                    <ForeName>Susan Mary</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author>
                    <LastName>Mawman</LastName>
                    <ForeName>Deborah Jane</ForeName>
                    <Initials>DJ</Initials>
                </Author>
                <Author>
                    <LastName>O'Driscoll</LastName>
                    <ForeName>Martin Paul</ForeName>
                    <Initials>MP</Initials>
                </Author>
                <Author>
                    <LastName>Evans</LastName>
                    <ForeName>Dafydd Gareth</ForeName>
                    <Initials>DG</Initials>
                </Author>
                <Author>
                    <LastName>Rutherford</LastName>
                    <ForeName>Scott Alexander</ForeName>
                    <Initials>SA</Initials>
                </Author>
                <Author>
                    <CollectiveName>Manchester Neurofibromatosis Type 2 Service</CollectiveName>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType UI="">JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Otol Neurotol</MedlineTA>
            <NlmUniqueID>100961504</NlmUniqueID>
            <ISSNLinking>1531-7129</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MAO.0000000000001166</ArticleId>
            <ArticleId IdType="pubmed">27525707</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
